http://www.reportbuyer.com/blog Sharing intelligence Thu, 20 Nov 2008 14:57:29 +0000 http://wordpress.org/?v=2.2 en http://www.reportbuyer.com/blog/astrazenecas-crestor-could-revolutionise-heart-disease-treatment/ http://www.reportbuyer.com/blog/astrazenecas-crestor-could-revolutionise-heart-disease-treatment/#comments Fri, 14 Nov 2008 16:28:16 +0000 Urmila Doraswami Pharma & Healthcare http://www.reportbuyer.com/blog/astrazenecas-crestor-could-revolutionise-heart-disease-treatment/ http://www.reportbuyer.com/blog/astrazenecas-crestor-could-revolutionise-heart-disease-treatment/feed/ http://www.reportbuyer.com/blog/sanofi-aventis-and-pfizer-stop-development-of-a-class-of-anti-obesity-drugs/ http://www.reportbuyer.com/blog/sanofi-aventis-and-pfizer-stop-development-of-a-class-of-anti-obesity-drugs/#comments Fri, 14 Nov 2008 16:14:23 +0000 Urmila Doraswami Pharma & Healthcare http://www.reportbuyer.com/blog/sanofi-aventis-and-pfizer-stop-development-of-a-class-of-anti-obesity-drugs/ http://www.reportbuyer.com/blog/sanofi-aventis-and-pfizer-stop-development-of-a-class-of-anti-obesity-drugs/feed/ http://www.reportbuyer.com/blog/pharma-companies-turn-webwards-to-recruit-patients-as-90-of-clinical-trials-face-delay/ http://www.reportbuyer.com/blog/pharma-companies-turn-webwards-to-recruit-patients-as-90-of-clinical-trials-face-delay/#comments Tue, 21 Oct 2008 10:09:27 +0000 Urmila Doraswami Pharma & Healthcare http://www.reportbuyer.com/blog/pharma-companies-turn-webwards-to-recruit-patients-as-90-of-clinical-trials-face-delay/ http://www.reportbuyer.com/blog/pharma-companies-turn-webwards-to-recruit-patients-as-90-of-clinical-trials-face-delay/feed/ http://www.reportbuyer.com/blog/have-your-healthcare-costs-reduced-with-personalized-healthcare/ http://www.reportbuyer.com/blog/have-your-healthcare-costs-reduced-with-personalized-healthcare/#comments Mon, 20 Oct 2008 15:31:58 +0000 Jonna Dagliden anderson cancer centerantipsychoticsbiotechnology companiesdrug resistanceengineering newsfuture rolegenetic testinggene expression profilegenotypegenotypinghealthcare costshealthcare enterpriseshiv infectionm d andersonm d anderson cancer centerneurological disordersPharma & Healthcarepharma industrysystems biologyunnecessary treatmentsyear 2012 http://www.reportbuyer.com/blog/have-your-healthcare-costs-reduced-with-personalized-healthcare/ http://www.reportbuyer.com/blog/have-your-healthcare-costs-reduced-with-personalized-healthcare/feed/ http://www.reportbuyer.com/blog/india-booming-economy-sees-the-pharmaceutical-market-expand/ http://www.reportbuyer.com/blog/india-booming-economy-sees-the-pharmaceutical-market-expand/#comments Tue, 07 Oct 2008 14:16:23 +0000 Analyst comment from RNCOS Pharma & Healthcarethe rblog http://www.reportbuyer.com/blog/india-booming-economy-sees-the-pharmaceutical-market-expand/ http://www.reportbuyer.com/blog/india-booming-economy-sees-the-pharmaceutical-market-expand/feed/ http://www.reportbuyer.com/blog/battle-for-hiv-drug-market-share-getting-fiercer-maybe-too-fierce-for-some/ http://www.reportbuyer.com/blog/battle-for-hiv-drug-market-share-getting-fiercer-maybe-too-fierce-for-some/#comments Thu, 02 Oct 2008 09:58:55 +0000 Mansi Shah Pharma & Healthcarethe rblog http://www.reportbuyer.com/blog/battle-for-hiv-drug-market-share-getting-fiercer-maybe-too-fierce-for-some/ http://www.reportbuyer.com/blog/battle-for-hiv-drug-market-share-getting-fiercer-maybe-too-fierce-for-some/feed/ http://www.reportbuyer.com/blog/will-government-support-see-indias-tourism-industry-reach-26-billion-by-2010/ http://www.reportbuyer.com/blog/will-government-support-see-indias-tourism-industry-reach-26-billion-by-2010/#comments Wed, 24 Sep 2008 15:53:21 +0000 Analyst comment from RNCOS Pharma & Healthcarethe rblog http://www.reportbuyer.com/blog/will-government-support-see-indias-tourism-industry-reach-26-billion-by-2010/ http://www.reportbuyer.com/blog/will-government-support-see-indias-tourism-industry-reach-26-billion-by-2010/feed/ http://www.reportbuyer.com/blog/despite-europe-driving-the-uptake-of-biosimilars-us-still-ahead-in-sales/ http://www.reportbuyer.com/blog/despite-europe-driving-the-uptake-of-biosimilars-us-still-ahead-in-sales/#comments Wed, 24 Sep 2008 11:41:57 +0000 Pam Narang anemiaanemia drugarthritisbiologicsdiseasesemergenceepoetin alphaextenthammering out the detailsindependent marketmarket analystmarket dominancemember statesmolecule drugsPharma & Healthcarepharmaceutical marketpharmacistsrecombinant growth hormonerelated research http://www.reportbuyer.com/blog/despite-europe-driving-the-uptake-of-biosimilars-us-still-ahead-in-sales/ http://www.reportbuyer.com/blog/despite-europe-driving-the-uptake-of-biosimilars-us-still-ahead-in-sales/feed/ http://www.reportbuyer.com/blog/obama-vs-mccain-who-leads-the-science-debate-2008/ http://www.reportbuyer.com/blog/obama-vs-mccain-who-leads-the-science-debate-2008/#comments Wed, 24 Sep 2008 09:50:03 +0000 Ruchi Mallya analyst firmbarack obamabiotechnology sectorsconcerned citizensdeveloped nationseyes and earsfull swingfuture stateindependent marketjohn mccainlife science researchmarket analystmathematicPharma & Healthcarepolitical dialoguescience debatescience programssenator barack obamasenator john mccainstate of americathe rblogwar in iraq http://www.reportbuyer.com/blog/obama-vs-mccain-who-leads-the-science-debate-2008/ http://www.reportbuyer.com/blog/obama-vs-mccain-who-leads-the-science-debate-2008/feed/ http://www.reportbuyer.com/blog/the-european-commission-approves-vimpat-for-treatment-of-epilepsy/ http://www.reportbuyer.com/blog/the-european-commission-approves-vimpat-for-treatment-of-epilepsy/#comments Tue, 16 Sep 2008 09:45:48 +0000 Analyst Comment from Datamonitor clinical trialsepilepsyepilepsy patientsepilepsy treatmenteuropean commissionlacosamidelevetiracetamnovel drugspartial onset seizurespatent expiryPharma & Healthcarephase iiirefractory epilepsyregulatory approvalrelated researchs markettreatment of epilepsyuncontrolled seizuresunmet need http://www.reportbuyer.com/blog/the-european-commission-approves-vimpat-for-treatment-of-epilepsy/ http://www.reportbuyer.com/blog/the-european-commission-approves-vimpat-for-treatment-of-epilepsy/feed/